Ennio Ongini
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
Journal: Investigative ophthalmology & visual science
Published: October 13, 2015
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
Journal: Orphanet journal of rare diseases
Published: February 24, 2015
Nitric oxide (NO): an emerging target for the treatment of glaucoma.
Journal: Investigative ophthalmology & visual science
Published: August 16, 2014
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
Journal: Human molecular genetics
Published: January 28, 2014
Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol.
Journal: Cardiovascular drugs and therapy
Published: February 13, 2013
Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Journal: PloS one
Published: July 19, 2012
Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice.
Journal: Muscle & nerve
Published: May 15, 2012
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
Journal: Cardiovascular research
Published: February 25, 2012
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Journal: PloS one
Published: February 02, 2012
The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye.
Journal: The British journal of ophthalmology
Published: January 20, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026